$5.80
-0.16-2.68%
In chiusura: -
$6.00
0.203.45%
After hour: Oct 31, 5:22 PM EDT
Comments
Loading...
Guidance e previsioni
Karyopharm Therapeutics fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/11/2025 | KPTI | Karyopharm Therapeutics | FY | 2025 | — | — | — | $140.00M | $155.00M | $148.22M | |
05/12/2025 | KPTI | Karyopharm Therapeutics | FY | 2025 | — | — | — | $140.00M | $155.00M | $149.62M | |
02/19/2025 | KPTI | Karyopharm Therapeutics | FY | 2025 | — | — | — | $140.00M | $155.00M | $165.50M | |
01/13/2025 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $145.00M | $145.00M | $152.89M | |
01/13/2025 | KPTI | Karyopharm Therapeutics | Q4 | 2024 | — | — | — | $30.00M | $30.00M | $38.20M | |
11/05/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $145.00M | $155.00M | $152.35M | |
08/06/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $145.00M | $160.00M | $145.44M | |
05/08/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $140.00M | $160.00M | $146.52M | |
02/29/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $140.00M | $160.00M | $152.02M | |
01/08/2024 | KPTI | Karyopharm Therapeutics | Q4 | 2023 | — | — | — | $33.60M | $33.60M | $37.64M | |
01/08/2024 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $146.00M | $146.00M | $150.03M | |
11/02/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $151.17M | |
08/02/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $150.34M | |
05/04/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $157.37M | |
02/15/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $160.00M | $175.00M | $163.24M | |
01/09/2023 | KPTI | Karyopharm Therapeutics | Q4 | 2022 | — | — | — | $34.20M | $34.20M | $38.13M | |
01/09/2023 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $157.70M | $157.70M | $161.68M | |
11/03/2022 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $155.00M | $165.00M | $157.23M | |
08/04/2022 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $155.00M | $165.00M | $160.03M |
FAQ
Qual è la guidance più recente per Karyopharm Therapeutics (KPTI)?
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Karyopharm Therapeutics.
Sfoglia guidance e previsioni su tutte le azioni.